NAS:ZYBT (China)
Â
Ordinary Shares - Class A
$
0.78
+0.030 (+4%)
11:08 PM EST
Business Description
Zhengye Biotechnology Holding Ltd
ISIN : KYG989MS1016
Share Class Description:
ZYBT: Ordinary Shares - Class ATotal Employee Number:
269Description
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry and other vaccines.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.69 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.3 | |||||
Debt-to-EBITDA | -1.78 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 0.88 | |||||
Beneish M-Score | -3.67 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -23.9 | |||||
3-Year Book Growth Rate | -6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 69.47 | |||||
9-Day RSI | 56.2 | |||||
14-Day RSI | 50.45 | |||||
3-1 Month Momentum % | -15.06 | |||||
6-1 Month Momentum % | -21.7 | |||||
12-1 Month Momentum % | -86.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.14 | |||||
Quick Ratio | 0.82 | |||||
Cash Ratio | 0.43 | |||||
Days Inventory | 196.45 | |||||
Days Sales Outstanding | 118.68 | |||||
Days Payable | 169.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | -15.36 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 20.41 | |||||
Operating Margin % | -58.79 | |||||
Net Margin % | -60.24 | |||||
EBITDA Margin % | -36.64 | |||||
FCF Margin % | 0.86 | |||||
OCF Margin % | 11.81 | |||||
ROE % | -25.45 | |||||
ROA % | -14.78 | |||||
ROIC % | -17.15 | |||||
3-Year ROIIC % | 241.94 | |||||
ROC (Joel Greenblatt) % | -23.15 | |||||
ROCE % | -19.89 | |||||
Years of Profitability over Past 10-Year | 4 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 2.25 | |||||
PB Ratio | 1.04 | |||||
Price-to-Tangible-Book | 1.34 | |||||
Price-to-Free-Cash-Flow | 260.01 | |||||
Price-to-Operating-Cash-Flow | 19.01 | |||||
EV-to-EBIT | -5.02 | |||||
EV-to-EBITDA | -8.09 | |||||
EV-to-Revenue | 2.96 | |||||
EV-to-FCF | 346.07 | |||||
Earnings Yield (Greenblatt) % | -19.92 | |||||
FCF Yield % | 0.38 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ZYBT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhengye Biotechnology Holding Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 16.352 | ||
| EPS (TTM) ($) | -0.208 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 116.28 | ||
| 14-Day RSI | 50.45 | ||
| 14-Day ATR ($) | 0.071933 | ||
| 20-Day SMA ($) | 0.756395 | ||
| 12-1 Month Momentum % | -86.56 | ||
| 52-Week Range ($) | 0.6155 - 13.08 | ||
| Shares Outstanding (Mil) | 47.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhengye Biotechnology Holding Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhengye Biotechnology Holding Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-16 | In 128 days | ||
| Second quarter earnings results for 2026 | 2026-08-13 | In 33 days | ||
| First quarter earnings results for 2026 | 2026-07-13 | In 2 days | ||
| Annual report for 2025 | 2026-04-28 | 0.88 (-2.10%) | ||
| Fourth quarter earnings results for 2025 | 2026-04-28 | 0.88 (-2.10%) | ||
| General meeting for 2025 | 2026-03-24 08:00 | 1.00 (+12.70%) | ||
| Annual report for 2024 | 2025-07-03 | 5.92 (-6.48%) | ||
| Fourth quarter earnings results for 2024 | 2025-07-03 | 5.92 (-6.48%) |
Show
Entries
Zhengye Biotechnology Holding Ltd Frequently Asked Questions
What is Zhengye Biotechnology Holding Ltd(ZYBT)'s stock price today?
The current price of ZYBT is $0.78. The 52 week high of ZYBT is $13.08 and 52 week low is $0.62.
When is next earnings date of Zhengye Biotechnology Holding Ltd(ZYBT)?
The next earnings date of Zhengye Biotechnology Holding Ltd(ZYBT) is 2026-07-13 Est..
Does Zhengye Biotechnology Holding Ltd(ZYBT) pay dividends? If so, how much?
Zhengye Biotechnology Holding Ltd(ZYBT) does not pay dividend.
Guru Commentaries on NAS:ZYBT
No articles.
Press Release
Articles on Zhengye Biotechnology Holding Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers